On May 24th, the French-American Chamber of Commerce New England will hold its 17th annual Business Awards. The FAB Awards is a competition rewarding innovative small, medium and large organizations.
Its role is to help companies located in New England that have a relationship with France develop their business and gain more visibility.
Its role is to help companies located in New England that have a relationship with France develop their business and gain more visibility.
The 2018 FAB Awards Jury met on April 17th -
Here are the finalists for the 17th FAB Awards!
'S' Small
|
'M' Medium
|
'L' Large
|
|
|
|
A look back to our 2017 winners!
|
|
|
Valéry Freland, Consul General of France in Boston
Jérôme Lefevre, Infotraffic, winner in the "Startups & Very Small Companies" category
Bruno Villaret, Mauna Kea Technologies, winner in the "Small & Medium Companies" category
Stéphane Bancel, Moderna Therapeutics, winner in the "Large Companies" category
Patrick Bian, FACCNE President
Ludivine Wolczik, FACCNE Executive Director
Jérôme Lefevre, Infotraffic, winner in the "Startups & Very Small Companies" category
Bruno Villaret, Mauna Kea Technologies, winner in the "Small & Medium Companies" category
Stéphane Bancel, Moderna Therapeutics, winner in the "Large Companies" category
Patrick Bian, FACCNE President
Ludivine Wolczik, FACCNE Executive Director
Testimonials
"Participating in the FACCNE's Annual Business Awards competition was an exciting milestone for Infotraffic in 2017. Our team was able to receive constructive feedback and advice from a qualified pitch coach, who was available for support throughout the process. The awards competition was a welcome challenge for Infotraffic to introduce its mission and services to a new, international audience. Since receiving the award for Best Startup, the Infotraffic team has been busy with projects along the East Coast in the US, as well as in Montreal and Ottawa. " - Infotraffic
"Moderna continued to progress rapidly its pipeline to the clinic. We announced positive phase 1 data for our first treatment with Astra-Zenaca. At the time of the FAB award, we had published our first successful vaccine phase 1 in human for Influenza. We company raised a $500m financing in early 2018. We now have 10 important medicines in clinical trials and 9 more on their way to the clinic. " - Moderna
"Moderna continued to progress rapidly its pipeline to the clinic. We announced positive phase 1 data for our first treatment with Astra-Zenaca. At the time of the FAB award, we had published our first successful vaccine phase 1 in human for Influenza. We company raised a $500m financing in early 2018. We now have 10 important medicines in clinical trials and 9 more on their way to the clinic. " - Moderna
Bravo 2017 runners-up!
|
STARTUPS & VERY SMALL COMPANIES
|
SMALL & MEDIUM COMPANIES
|
LARGE COMPANIES
|
This event is made possible by the generous support from our event sponsors
Dassault Systèmes, Nanobiotix & Pact&Partners!
Dassault Systèmes, Nanobiotix & Pact&Partners!
|
Dassault Systèmes, the 3DEXPERIENCE
Company, provides business and people with virtual universes to imagine sustainable innovations. |
Nanobiotix is a late stage clinical company pioneering nanomedicine for more than a decade.
|
Pact & Partners, the leading Executive Search firm specialized in Life Sciences since 1987.
|
thank you to our annual sponsors
|
|
|
|
|
|
|
|
|
|
|
|
|
Photo credit - header
Jon Holiday http://fineartamerica.com/featured/boston-back-bay-skyline-at-night-color-panorama-jon-holiday.html
Jon Holiday http://fineartamerica.com/featured/boston-back-bay-skyline-at-night-color-panorama-jon-holiday.html